Fig. 2From: A cohort study evaluating the association between concurrent mental disorders, mortality, morbidity, and continuous treatment retention for patients in opioid agonist treatment (OAT) across Ontario, Canada, using administrative health dataProportion of diagnoses of mental disorders for patients enrolled in OATBack to article page